Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TOIIW | US
-0.00
-1.41%
Healthcare
Medical Care Facilities
30/06/2024
14/04/2026
0.05
0.05
0.05
0.05
The Oncology Institute Inc. an oncology company provides medical oncology services in the United States. Its services include physician services in-house infusion and dispensary clinical trial services outpatient stem cell transplants and transfusions programs and patient support. The company also offers and manages clinical trial services such as managing clinical trials palliative care programs and stem cell transplants for cancer patients. The company was founded in 2007 and is based in Cerritos California.
View LessLow Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
471.8%1 month
374.4%3 months
450.0%6 months
360.6%-
-
-
4.14
0.67
-
-
-
-57.34M
-
-
-
-16.60
-
22.90
-125.59
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.04
Range1M
0.05
Range3M
0.17
Rel. volume
1.29
Price X volume
741.28
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| PIIIW | PIIIW | Medical Care Facilities | 0.0054 | 0 | 22.73% | n/a | 87.60% |
| Guardian Pharmacy Services Inc. | GRDN | Medical Care Facilities | 37.79 | 0 | -4.30% | n/a |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| RenaissanceRe Holdings Ltd. | RNR-PG | Insurance-Reinsurance | 15.8401 | 0 | 1.02% | n/a | 19.26% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | 13.85 | - |
| Ent. to Revenue | - | 1.73 | - |
| PE Ratio | - | 22.94 | - |
| Price to Book | - | 14.91 | - |
| Dividend Yield | - | 1.25 | - |
| Std. Deviation (3M) | 450.02 | 51.88 | Riskier |
| Debt to Equity | 4.14 | 5.15 | Par |
| Debt to Assets | 0.67 | 0.46 | Expensive |
| Market Cap | - | 6.67B | - |